Brief Description
Fluxion Biosciences provides analytical, live cell analysis tools that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms in physiologically relevant micro-environments, Fluxion helps bridge the translational medicine gap by bringing research data closer to patients. Fluxion's innovative systems for live cell analysis are enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
The company successfully introduced three different instrumentation platforms to the market, now utilized by clinical, translational, and basic researchers across more than 300 global sites. Fluxion Biosciences was co-founded by Dr. Michelle Khine, who received her BS and MS in Mechanical Engineering (’99 and ’01, respectively) and her PhD in Bioengineering (’05) from UC Berkeley, Berkeley Researcher Dr. Cristian Ionescu-Zanetti, and Michael Schwartz (Berkeley BS Bioengineering).
Timeline
- 2005. Company founded.
- 2023. Acquired by Cell Microsystems.
Inventors
Adrian Lau, Cristian Ionescu Zanetti, Jeonggi Seo, Luke Lee, Michelle Khine, Poorya Sabounchi, Robin Shaw